SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending despite a significant intraday drop following news of a $5 billion AI infrastructure lease, with community members pointing to potential short-selling tactics or market manipulation. The community is actively discussing the long-term implications of the deal, speculating on the identity of the hyperscaler involved (potential partnership with Oracle). Many express bullish sentiment based on the company's fundamentals and the potential for long-term growth in the AI sector, viewing the current price action as a buying opportunity.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

UUUU is trending due to increased investor interest in uranium and rare earth elements, particularly amid growing tensions between the US and China regarding trade and national security. Community members are discussing the company's potential to benefit from government initiatives to secure domestic supply chains and reduce reliance on China, as well as unusual call option activity. The stock is also gaining attention for its unique position as a US company processing both uranium and rare earth elements.

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.

Armata Pharmaceuticals Inc

Armata Pharmaceuticals is trending due to positive Phase 2a clinical trial results for its AP-SA02 drug targeting Staphylococcus aureus bacteremia, with potential as a new standard of care; the study showed high responder rates and zero relapse in MRSA cases. The community is discussing the potential for a Phase 3 study and commercialization, but also noting the company's cash position and potential for future offerings, as well as potential government stake.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending as discussions revolve around its potential acquisition of Larvotto Resources and the implications for its position as a key antimony supplier outside of China. Community members are analyzing the deal's potential benefits, government involvement, and the impact of Trump's meeting with the Australian Prime Minister on critical minerals, while also weighing in on short-term volatility.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to a recent earnings report, with discussions focusing on a miss attributed to a one-time Brazilian tax issue, despite revenue growth and strong viewership numbers. The community is debating whether this is a buying opportunity or the start of a deeper decline, also noting surging ad revenue and potential impacts from strategic price hikes. Some bearish sentiment is fueled by concerns over valuation and broader market conditions, while others point to positive analyst ratings and potential for a quick recovery.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending following a strong Q3 earnings report, highlighted by a significant EPS beat and revenue growth, leading to analyst upgrades. Community discussion revolves around the initial positive reaction and whether the gains are sustainable, as well as the impact of strong da Vinci and Ion system sales. The company's performance is being compared to other trending tickers, with some investors noting potential portfolio correlations.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending downwards, retracing after a rally, leading to community discussions about support levels and potential bottom. Community members are debating whether to buy the dip or wait for further correction, while highlighting the company's fundamentals and long-term potential in the AI sector. Despite the recent pullback, some investors express confidence in NBIS, pointing to the company's AI infrastructure and strategic partnerships, while others are concerned about the stock's valuation and potential for further decline.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending due to recent data from its cystic fibrosis program, ARCT-032, showing mucus reduction but limited lung function improvement, leading to community debate about the results' implications. Despite the mixed data, some analysts remain optimistic, pointing to the company's broader pipeline and potential catalysts like CSL royalties and possible acquisition interest, while others express disappointment and skepticism. Discussions also involve the company's cash position and lawsuit with AbbVie.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending amid discussion of its recent earnings report and the broader implications for the company's future. Community members are weighing the significance of the earnings against market factors, while also pointing to the company's potential in AI and data centers. Investors are closely monitoring price movements and debating whether the stock presents a buying opportunity.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending as investors discuss the stock's potential due to its partnerships, particularly with Anduril, and growing interest in defense technology. Bullish sentiment is fueled by discussions of uplisting to major exchanges and the increasing demand for subsea technology. The community is also focused on Kraken's role in the expanding market for unmanned underwater vehicles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Welcome to @Cashvisory_India&#39;s Ask Me Anything (AMA)!  We are a SEBI RIA and VC funded fintech, with a mission to get every single Indian to their first investment. 
 
From the lens of long term wealth creation, if you have any burning questions about your current or prospective investments, feel free to drop in your questions.  
 
$NIFTY50.NSE $NIFTYBANK.NSE $ASK.P

Chaitanya Gupta

Stocktwits India

ProfitPapi

Rajni Murugan

Ajay

Satvik Tayal

Tanmoy ghosh

Abhudit Greene

Vansh

Anil Kumar

Teekx Dhadda

Ananya Poddar

Shiv Sharma

Prateek

$NIFTY50.NSE $NIFTYBANK.NSE $ASK.P  $UJJIVANSFB.NSE  what to do?

StockTwits For Android 

Info SysO

Sanjay Jain

Have any query on your current or prospective investments? @Cashvisory_India is hosting an AMA and sharing their views on your queries! Go ahead and drop your questions in their comments below 👇 
 
$NIFTY50.NSE $NIFTYBANK.NSE $ASK.P

StockTwits Web

The Nifty 50 is seeing increased community interest amidst quadrant change alerts and discussions around the optimal entry point for Q2. Top themes driving conversation include themes like double-digit growth and market leaders. Additionally, U.S. President Trump's planned meeting with China's Xi and its potential impact on trade tensions are being closely monitored.

Ask The Community

Welcome to @Cashvisory_India's Ask Me Anything (AMA)!  We are a SEBI RIA and VC funded fintech, with a mission to get every single Indian to their first investment. 
 
From the lens of long term wealth creation, if you have any burning questions about your current or prospective investments, feel free to drop in your questions.  
 


This account has been verified as a SEBI Registered Investment Adviser (RIA).

Verified SEBI RIA Account

SEBI Registered Robo-advisor

@Cashvisory_India  
Long term target for $ZOMATO.NSE

Eternal Ltd.

@Cashvisory_India @Cashvisory_India $EMSLIMITED.NSE $JKIL.NSE target

J.Kumar Infraprojects Ltd

EMS Ltd.

anil anu

@Cashvisory_India $HINDPETRO.NSE is good for a swing trade?

StockTwits for iOS

Hindustan Petroleum Corporation Ltd.

Harshala Chavan

@Cg_1999 $Zomato is definitely a good long term prospect but high valuation is a concern. 
 
Positives: 
- Good EPS growth trends and expected to continue at over 40% growth. 
- Robust growth for Blinkit 
- Increase in GOV by 28% in the food delivery business and overall cost reduction. 
 
Hence, we foresee a 20-30% upside in the stock price from current levels over the next year and a half, but with  growth stocks like Zomato, volatility will persist and one needs to be cautious and patient for longer term gains. 
 
Even with current high EPS growth projections, the valuations are not justified. We would wait for dips in the stock price and dollar cost average in the long run.

 $Zomato is definitely a good long term prospect but high valuation is a concern. 
 
Positives: 
- Good EPS growth trends and expected to continue at over 40% growth. 
- Robust growth for Blinkit 
- Increase in GOV by 28% in the food delivery business and overall cost reduction. 
 
Hence, we foresee a 20-30% upside in the stock price from current levels over the next year and a half, but with  growth stocks like Zomato, volatility will persist and one needs to be cautious and patient for longer term gains. 
 
Even with current high EPS growth projections, the valuations are not justified. We would wait for dips in the stock price and dollar cost average in the long run.

@vedavath  
 
For $EMSLIMITED.NSE: We are bullish on the long term prospects. 
 
Positives: 
- Substantial order book that is expected to grow 
- Healthy consistent ROE of 24.14% and ROCE of 32.31% 
- High operating margin of 29.69% 
- PE of 30 as comapred to industry PE of 42 
- Projected revenue growth of 35% for FY25 
- Very low debt for similar companies 
 
We see an upside of at-least 25% in 12-18 months and very good long term growth prospects as infra continues to be in focus in India.

vivek pandya

Sagar Kanojia

: We are bullish on the long term prospects. 
 
Positives: 
- Substantial order book that is expected to grow 
- Healthy consistent ROE of 24.14% and ROCE of 32.31% 
- High operating margin of 29.69% 
- PE of 30 as comapred to industry PE of 42 
- Projected revenue growth of 35% for FY25 
- Very low debt for similar companies 
 
We see an upside of at-least 25% in 12-18 months and very good long term growth prospects as infra continues to be in focus in India.

@Cashvisory_India @Cashvisory_India 
2024 target for cochin shipyard

Sree Shankar

@Cashvisory_India @Cashvisory_India your view on Akums drugs and pharmaceuticals

 your view on Akums drugs and pharmaceuticals

Prajval G

@Cashvisory_India @Cashvisory_India  
$Atgl price Target

ALPHA TECHNOLOGY GROUP LTD

misba khanum

@Cashvisory_India @Cashvisory_India 
I bought 
BEST AGRO LIFE @ 719
CMP - 595 
Qty- 60 
Present loss -7400 .
What is its future? What shall I do? $BESTAGRO.NSE

Best Agrolife Ltd.

 
I bought 
BEST AGRO LIFE @ 719
CMP - 595 
Qty- 60 
Present loss -7400 .
What is its future? What shall I do? 

Akash shah

@Cashvisory_India what to do with $UJJIVANSFB.NSE holded 1000 share from

Ujjivan Small Finance Bank Limited

@Cashvisory_India @Cashvisory_India 
You view on $TITAGARH.NSE ( I&#39;m looking for more downside till 1400) and $ASIANPAINT.NSE ( for me potential going up for around 3250 or more) and $$KALYANKJIL.NSE 

Thank you in advance

Asian Paints Ltd.

Kalyan Jewellers India Ltd.

Titagarh Rail Systems Ltd.

 ( I'm looking for more downside till 1400) and 

 ( for me potential going up for around 3250 or more) and $$KALYANKJIL.NSE 

Thank you in advance

Shubh Agarwal

@Cashvisory_India @Cashvisory_India from a swing trading perspective, how much should I aim for in a month, I don&#39;t want to hold stocks for too long and I have multiple targets where I offload shares, what would be a realistic strategy to increase my returns?

 from a swing trading perspective, how much should I aim for in a month, I don't want to hold stocks for too long and I have multiple targets where I offload shares, what would be a realistic strategy to increase my returns?

Roopesh R

@Roopesh80 we aren&#39;t swing trading experts. We believe in and implement a long term value investing strategy. So we can&#39;t really help you out here. 
 
The reason for our approach is going with time tested strategies that work with low effort. If you are a full time trader, only then can trading work and it still might not as most traders don&#39;t even beat the indices.

 we aren't swing trading experts. We believe in and implement a long term value investing strategy. So we can't really help you out here. 
 
The reason for our approach is going with time tested strategies that work with low effort. If you are a full time trader, only then can trading work and it still might not as most traders don't even beat the indices.

@harshalachavan7 Swing trading is not our forte. And we will not be in a position to advise.  
 
However, from a longer term perspective: 
 
Upsides:  
- Good dividend yield of 5.33% 
- Annual Net Profit rose 329.43% in the last year, beating industry avg. of 74% 
- PE of 8.5, lower than industry peers 
- Consistent ROCE of 13.9% in the last 3 years 
 
We see a potential upside of 10-20% in the stock in 12-18 months and we expect the sector and company to do well moving ahead.

 Swing trading is not our forte. And we will not be in a position to advise.  
 
However, from a longer term perspective: 
 
Upsides:  
- Good dividend yield of 5.33% 
- Annual Net Profit rose 329.43% in the last year, beating industry avg. of 74% 
- PE of 8.5, lower than industry peers 
- Consistent ROCE of 13.9% in the last 3 years 
 
We see a potential upside of 10-20% in the stock in 12-18 months and we expect the sector and company to do well moving ahead.

@S__k $COCHINSHIP.NSE  
has a promising long-term outlook but comes with significant valuation concerns. 
 
Positives: 
- Order Book: As of Q3 FY24, the order book stands at ₹21,500 crore, with 52% allocated to green vessels. It includes ₹16,064 crore in defense orders and ₹700 crore in ship repair orders 
- Order Pipeline: ₹9,000 crore in potential new orders supports future growth 
- Debt Management: The company is practically debt-free after redeeming ₹100 crore in tax-free bonds 
 
Valuation Concerns: 
- High Valuation: P/E ratio of 82 and PEG ratio of 7.3 
- Sales Growth: Modest growth of 4.21% over the past five years 
- ROE: Low at 12.7% over the last three years 
- Earnings Composition: Includes ₹307 crore of other income 
 
Outlook: 
We are concerned about valuations and would avoid for 2024. Only go in if there are significant corrections.

Cochin Shipyard Ltd

  
has a promising long-term outlook but comes with significant valuation concerns. 
 
Positives: 
- Order Book: As of Q3 FY24, the order book stands at ₹21,500 crore, with 52% allocated to green vessels. It includes ₹16,064 crore in defense orders and ₹700 crore in ship repair orders 
- Order Pipeline: ₹9,000 crore in potential new orders supports future growth 
- Debt Management: The company is practically debt-free after redeeming ₹100 crore in tax-free bonds 
 
Valuation Concerns: 
- High Valuation: P/E ratio of 82 and PEG ratio of 7.3 
- Sales Growth: Modest growth of 4.21% over the past five years 
- ROE: Low at 12.7% over the last three years 
- Earnings Composition: Includes ₹307 crore of other income 
 
Outlook: 
We are concerned about valuations and would avoid for 2024. Only go in if there are significant corrections.

@Prajval_Govin  
 
General disclaimer: IPOs are generally risky as price discovery happens over a period of time. However: 
 
Akums Drugs is the new pharma on the block.   
 
Upsides:  
- In the unlisted market, the company&#39;s shares are trading at a GMP of Rs 170, which translates into a premium of 25% over the issue price.  
- The co has a strong track record, a large clientele, strong R&amp;D resources, and a key position in the pharmaceutical value chain.  
 
Downsides:  
- The company is raising money to prepay or repay debt of parent and subsidiary companies, and to fund working capital needs, hence this might suggest issues with cashflow utilization and optimization, hindering growth in a capex heavy business. 
- Akums Drugs and Pharma reported a profit of 0.79 crore with a revenue of Rs 4,212.21 crore for the year ended on March 31, 2024. 
 
We recommend waiting and watching for now.

  
 
General disclaimer: IPOs are generally risky as price discovery happens over a period of time. However: 
 
Akums Drugs is the new pharma on the block.   
 
Upsides:  
- In the unlisted market, the company's shares are trading at a GMP of Rs 170, which translates into a premium of 25% over the issue price.  
- The co has a strong track record, a large clientele, strong R&D resources, and a key position in the pharmaceutical value chain.  
 
Downsides:  
- The company is raising money to prepay or repay debt of parent and subsidiary companies, and to fund working capital needs, hence this might suggest issues with cashflow utilization and optimization, hindering growth in a capex heavy business. 
- Akums Drugs and Pharma reported a profit of 0.79 crore with a revenue of Rs 4,212.21 crore for the year ended on March 31, 2024. 
 
We recommend waiting and watching for now.

@misba786  
 
$ATGL.NSE shows strong performance but carries a high valuation, which poses potential risks. 
 
Positives: 
- Strong Volume Growth: CNG volumes grew by 24% in Q3 and 21% in the nine-month period. PNG volumes also showed growth, though at a slower rate. 
- Robust Profitability: EBITDA increased by 26% in Q3 and 20% in the nine-month period. PAT also saw strong growth of 16% in Q3 and 15% in the nine-month period. 
 
Concerns: 
- High Valuation: The PE ratio of 145.60 is significantly higher than the industry average of 18.56. 
 
Outlook: 
 
We would currently stay away due to very high valuations

Adani Total Gas Ltd.

 shows strong performance but carries a high valuation, which poses potential risks. 
 
Positives: 
- Strong Volume Growth: CNG volumes grew by 24% in Q3 and 21% in the nine-month period. PNG volumes also showed growth, though at a slower rate. 
- Robust Profitability: EBITDA increased by 26% in Q3 and 20% in the nine-month period. PAT also saw strong growth of 16% in Q3 and 15% in the nine-month period. 
 
Concerns: 
- High Valuation: The PE ratio of 145.60 is significantly higher than the industry average of 18.56. 
 
Outlook: 
 
We would currently stay away due to very high valuations

@SrjSuraj  
 
Ujjivan Small Finance Bank presents a mixed profile with strong dividend yield and profit growth, but some concerns regarding financial ratios and stock performance. 
 
Positives: 
- Profit Growth: The company has delivered an impressive profit growth of 45.0% CAGR over the last 5 years, reflecting strong financial performance. 
- Strong Loan Book Growth: Disbursements grew to INR 5,286 crores in Q1, contributing to a gross loan book of INR 30,069 crores. 
- Increased Institutional Holdings: FII holding increased significantly from 3.48% to 24.68%, and DIIs holding rose from 2.33% to 7.33%. 
- Valuation Metrics: The PE ratio of 6.77 is significantly below the industry average of 12.20. PEG ratio is very low at 0.15. 
 
Concerns: 
- Low Interest Coverage Ratio: The company has a low interest coverage ratio, which may indicate challenges in covering interest expenses with operating income. 
 
Currently it&#39;s a hold rating from us.

  
 
Ujjivan Small Finance Bank presents a mixed profile with strong dividend yield and profit growth, but some concerns regarding financial ratios and stock performance. 
 
Positives: 
- Profit Growth: The company has delivered an impressive profit growth of 45.0% CAGR over the last 5 years, reflecting strong financial performance. 
- Strong Loan Book Growth: Disbursements grew to INR 5,286 crores in Q1, contributing to a gross loan book of INR 30,069 crores. 
- Increased Institutional Holdings: FII holding increased significantly from 3.48% to 24.68%, and DIIs holding rose from 2.33% to 7.33%. 
- Valuation Metrics: The PE ratio of 6.77 is significantly below the industry average of 12.20. PEG ratio is very low at 0.15. 
 
Concerns: 
- Low Interest Coverage Ratio: The company has a low interest coverage ratio, which may indicate challenges in covering interest expenses with operating income. 
 
Currently it's a hold rating from us.

@Akash182  
 
$BESTAGRO.NSE:  
 
Seasonal failures for the company and pricing pressure due to oversupply from China has been affecting business. The company is launching 4 patented products this year and is bullish on this year&#39;s production.  
 
Upsides:  
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.3% 
- PE TTM of 13.4 below the industry levels of 37. 
 
Downsides 
- Company has negative cash flow from operations of -128.01. 
- Reducing EPS over the last year. 
 
We are on the fence. So a hold rating currently.

:  
 
Seasonal failures for the company and pricing pressure due to oversupply from China has been affecting business. The company is launching 4 patented products this year and is bullish on this year's production.  
 
Upsides:  
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.3% 
- PE TTM of 13.4 below the industry levels of 37. 
 
Downsides 
- Company has negative cash flow from operations of -128.01. 
- Reducing EPS over the last year. 
 
We are on the fence. So a hold rating currently.

@Cashvisory_India 
Holding above 2700levl,is it worth to hold

 hold it

 
Holding above 2700levl,is it worth to hold

 hold it

@Cashvisory_India $BESTAGRO.NSE 
Target and duration?

@S__k We would consider booking profits and offloading.

 We would consider booking profits and offloading.

@Shubh_01 $TITAGARH.NSE We agree there&#39;s more downside. It was fairly overvalued like some of the other railway stocks. So 1 weak quarter can lead to such slides.   
  
The company seems to have a strong hold on the Indian railway production market, it Achieved highest ever turnover last FY and is set to do a CAPEX of earmarked at INR 1,000 crores over the next couple of years.   
  
Upsides:   
- Consistent EPS of 21  
- The company has shown a  a good profit growth of 48.78% and good revenue growth of 23.28% for the Past 3 years  
  
Downsides:  
- High PE TTM of 69  
- Poor operating numbers recently  
  
In the long term the company is pitted to be a strong one in the rail systems industry, however short term buy-sell pressures might make the stock volatile, hence we recommend buying during the dips and staying invested for long.

 We agree there's more downside. It was fairly overvalued like some of the other railway stocks. So 1 weak quarter can lead to such slides.   
  
The company seems to have a strong hold on the Indian railway production market, it Achieved highest ever turnover last FY and is set to do a CAPEX of earmarked at INR 1,000 crores over the next couple of years.   
  
Upsides:   
- Consistent EPS of 21  
- The company has shown a  a good profit growth of 48.78% and good revenue growth of 23.28% for the Past 3 years  
  
Downsides:  
- High PE TTM of 69  
- Poor operating numbers recently  
  
In the long term the company is pitted to be a strong one in the rail systems industry, however short term buy-sell pressures might make the stock volatile, hence we recommend buying during the dips and staying invested for long.

@Akash182 We don&#39;t do price targets. But waiting and watching for the next year could be the course of action.

 We don't do price targets. But waiting and watching for the next year could be the course of action.